You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oasmia launches its ovarian cancer treatment drug in Sweden, Denmark and Finland
Oasmia Pharmaceutical is launching its product, Apealea 60 mg, an ovarian cancer treatment drug, in Sweden, Denmark and Finland.
The first batch of the drug has been shipped to distributors in these countries, states the company.
Transition towards becoming a fully integrated pharmaceutical comp
